首页 | 本学科首页   官方微博 | 高级检索  
     


Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers
Authors:Iwamoto Kunihiro  Kawamura Yukiko  Takahashi Masahiro  Uchiyama Yuji  Ebe Kazutoshi  Yoshida Keizo  Iidaka Tetsuya  Noda Yukihiro  Ozaki Norio
Affiliation:Department of Psychiatry, Nagoya University, Graduate School of Medicine, Aichi, Japan.
Abstract:
Aims: Amitriptyline triggers the impairment of cognitive and motor functions and has been confirmed to have harmful effects on driving performance. Although interindividual differences in plasma concentration may cause variations in driving performance, the relationship between plasma amitriptyline concentration and its effect on driving performance has not been completely elucidated. Thus, the aim of the present study was to assess the influence of individual pharmacokinetic differences on driving performance and cognitive functions. Methods: In this double‐blinded study, 17 healthy male volunteers were given an acute, single, 25‐mg dose of amitriptyline. The subjects were assigned three driving simulator tasks, three cognitive tasks, and the questionnaire of the Stanford Sleepiness Scale at the baseline and at 4 h after dosing. The plasma amitriptyline concentrations were measured on high‐performance liquid chromatography. Results: A significant positive correlation was observed between the plasma amitriptyline concentration and road‐tracking performance (r = 0.543, P < 0.05). There was no significant correlation between the plasma amitriptyline concentration and other driving performance, cognitive functions, and subjective somnolence. Conclusions: Amitriptyline produces a concentration‐related impairment on road‐tracking performance. Therapeutic monitoring of amitriptyline would be useful for predicting the difficulties involved while driving.
Keywords:amitriptyline  antidepressants  automobile driving  cognition  drug monitoring
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号